Publicaciones en colaboración con investigadores/as de University of Michigan Medical School (5)

2022

  1. Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy (Nature Medicine, (2022), 28, 3, (557-567), 10.1038/s41591-022-01696-4)

    Nature Medicine

  2. Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy

    Nature Medicine, Vol. 28, Núm. 3, pp. 557-567

2002

  1. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-κB activation

    Journal of Biological Chemistry, Vol. 277, Núm. 44, pp. 41701-41705

2000

  1. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-x(L)

    Journal of Experimental Medicine, Vol. 191, Núm. 6, pp. 977-984

1999

  1. Erythropoietin can induce the expression of Bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines

    Journal of Biological Chemistry, Vol. 274, Núm. 32, pp. 22165-22169